Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic contributions to left ventricular hypertrophy.

D K Arnett1

  • 1Division of Epidemiology, School of Public Health, University of Minnesota, 1300 South Second Street, Suite 300, Minneapolis, MN 55454, USA. arnett@epi.umn.edu

Current Hypertension Reports
|September 12, 2000
PubMed
Summary

Left ventricular hypertrophy, a heart condition affecting cardiovascular health, is influenced by multiple genes interacting with environmental factors. Understanding its genetic basis is key to managing this common disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry.

The pharmacogenomics journal·2019
Same author

Corrigendum: Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study.

Human molecular genetics·2018
Same author

APOL1, CDKN2A/CDKN2B, and HDAC9 polymorphisms and small vessel ischemic stroke.

Acta neurologica Scandinavica·2017
Same author

Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study.

Human molecular genetics·2017
Same author

CPT1A methylation is associated with plasma adiponectin.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2017
Same author

A DNA methylation biomarker of alcohol consumption.

Molecular psychiatry·2016

Area of Science:

  • Cardiology
  • Genetics
  • Pathophysiology

Background:

  • Left ventricular (LV) hypertrophy significantly increases cardiovascular disease risk, including heart attack, heart failure, and stroke.
  • Noninvasive imaging has improved the evaluation of cardiac structure and function, advancing the understanding of LV hypertrophy's natural history.
  • While hypertension is a known factor, it doesn't fully explain variations in LV mass, and LV hypertrophy can occur independently of or precede hypertension.

Purpose of the Study:

  • To provide an overview of the epidemiology and pathophysiology of LV hypertrophy and dysfunction.
  • To present evidence supporting the genetic basis of LV hypertrophy.
  • To identify potential candidate genes involved in LV hypertrophy development.

Main Methods:

Related Experiment Videos

  • Review of epidemiological data on LV hypertrophy.
  • Analysis of pathophysiological mechanisms underlying LV hypertrophy.
  • Examination of genetic studies implicating specific genes in LV hypertrophy.

    • Main Results:

    • LV hypertrophy is a complex condition with multifactorial etiology, involving gene-gene and gene-environment interactions.
    • Candidate genes related to LV structure, cell signaling, hormones, growth factors, calcium homeostasis, and blood pressure are implicated.
    • Genetic factors play a significant role in the development of LV hypertrophy, beyond the influence of blood pressure.

    Conclusions:

    • LV hypertrophy is a genetically influenced condition with significant clinical implications.
    • Further research into the genetic underpinnings of LV hypertrophy is crucial for developing targeted therapies.
    • Understanding the interplay between genetics and environment is essential for managing LV hypertrophy and reducing cardiovascular morbidity and mortality.